A cross-sectional analysis of post-acute COVID-19 symptoms
Keywords:
SARS CoV-2, Post-COVID-19 syndrome, Persistent symptoms, Organ dysfunctionAbstract
Objectives. The severe acute respiratory syndrome (COVID-19) due to SARS-CoV-2 was first reported in China in December 2019 and has generated a worldwide pandemic. The objective of the research is to examine and describe (a) the symptoms that persist after the end of the acute stage and (b) their relationship with the severity of the disease.
Study Design. This study is a cross-sectional study conducted in the Kingdom of Bahrain on COVID-19 infected patients using an online survey questionnaire with a total number of 52 patient responses (29 females and 23 males).
Method. A scale (0 no symptoms to 10 very high symptoms intensity) was assessed in patients after 3 months to detect the relevance of specific symptoms post-COVID-19 such as emotional and physical health, headache, dyspnoea, pain (muscles/joints/chest), anosmia, vertigo, neurologic symptoms, sarcopenia, delirium.
Results. The most common COVID-19 symptoms were reported to be fever (69.2%), headache (59.6%), and cough (50.0%). Data analysis showed that BMI was not correlated with any post-acute COVID-19 symptoms. Regarding the post-acute COVID-19 symptoms, this study showed that an increase of intensity of headache was associated with an increase of delirium; an increase of intensity of dyspnoea was associated with an increase of pulmonary dysfunction. The increase of anosmia and dysgeusia was associated with an increase in delirium. In addition, the increase of neurological symptoms and delirium were associated with the increase of sarcopenia. The most common persistent post-COVID-19 symptoms observed in this study were emotional stress, followed by loss of smell and taste, and neurological symptoms.
Conclusions. Therefore, follow-up and rehabilitation care for COVID-19 patients must be focused on addressing the needs of these people in the longer term.
References
1. Demeco A, Marotta N, Barletta M, et al. Rehabilitation of patients post-COVID-19 infection: a literature review. J Int Med Res 2020 Aug; 48(8): 030006052094838. doi:
10.1177/0300060520948382.
2. Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A crosssectional evaluation. J Med Virol 2021 Feb; 93(2): 1013-22. doi: 10.1002/jmv.26368. Epub 2020 Aug 17.
3. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. J Adv Res 2020 Mar 16; 24: 91-8. doi:
10.1016/j.jare.2020.03.005.
4. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020 Mar 5; 382(10): 970-1. doi: 10.1056/ NEJMc2001468. Epub 2020 Jan 30.
5. Borges do Nascimento IJ, Cacic N, Abdulazeem
HM, et al. Novel Coronavirus Infection (COVID-19) in Humans: A Scoping Review and Meta-Analysis. J Clin Med 2020 Mar 30; 9(4): 941. doi: 10.3390/jcm9040941.
6. Zou L. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 382(12): 1177-9. doi: 10.1056/ NEJMc2001737. Epub 2020 Feb 19.
7. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect 2020 Jun 17; 105(3): 587. doi: 10.1016/j.jhin.2020.06.001.
8. Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect Dis 2020 Oct 21; 7(12): ofaa509. doi: 10.1093/ofid/ ofaa509.
9. Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA Aug 11. 2020; 324(6): 603-5. Aug 11; 324(6): 6003-5. doi: 10.1001/jama.2020.12603.
10. Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2021 Feb; 27(2): 258-63. doi: 10.1016/j.cmi.2020.09.052. Epub 2020 Oct 5.
11. Del Rio C, Collins LF, Malani P. Longterm Health Consequences of COVID-19. JAMA 2020; 324(17): 1723-4. doi: 10.1001/ jama.2020.19719.
12. Sampaio Rocha-Filho PA, Voss L. Persistent Headache and Persistent Anosmia Associated With COVID-19. Headache 2020 Sep; 60(8): 1797-9. doi: 10.1111/head.13941. Epub 2020 Aug 26.
13. Kamal M, Abo Omirah M, Hussein A, Saeed
H. Assessment and characterisation of postCOVID-19 manifestations. Int J Clin Pract 2020 Sep 29: e13746. doi: 10.1111/ijcp.13746. Epub ahead of print.
14. Levinson R, Elbaz M, Ben-Ami R, et al. Anosmia and dysgeusia in patients with mild SARSCoV-2 infection. Infect Dis (Lond) 2020 Aug; 52(8): 600-602. doi: 10.1080/23744235.2020.1 772992.15.
15. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ 2020 Aug 11; 370: m3026. doi: 10.1136/bmj.m3026.
16. Gregson J, Kaptoge S, Bolton T, et al. Cardiovascular Risk Factors Associated with Venous Thromboembolism. JAMA Cardiol 2019 Feb 1; 4(2): 163-73. doi: 10.1001/jamacardio. 2018. 4537.
17. Popkin BM, Du S, Green WD, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev 2020 Nov; 21(11): e13128. doi: 10.1111/obr.13128. Epub 2020 Aug 26.
18. Killerby ME, Link-Gelles R, Haight SC, et al.
Characteristics Associated with Hospitalization Among Patients with COVID-19 - Metropolitan Atlanta, Georgia, March-April 2020. MMWR Morb Mortal Wkly Rep 2020 Jun 26; 69(25): 790-4. doi: 10.15585/mmwr.mm6925e1.
19. Kopel J, Perisetti A, Roghani A, Aziz M,
Gajendran M, Goyal H. Racial and GenderBased Differences in COVID-19. Front Public Health 2020 Jul 28; 8: 418. doi: 10.3389/ fpubh.2020.00418.
20. Rogers JP, Chesney E, Oliver D, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020 Jul; 7(7): 611-27. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.